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The prevalence of CCS in patients with AF var‑
ies from 17% to 47%,3,6,7 whereas AF in patients 
with CCS is much less common, ranging from 
0.2% to 5%.8-12 Patients with AF more often have 
concomitant CCS as compared with sinus rhythm 
controls.13,14 Additionally, AF is more frequent‑
ly present in patients with either peripheral or 
cerebrovascular artery disease than in nonath‑
erosclerotic individuals.15
INTROduCTION Atrial fibrillation (AF) is 
the most common cardiac arrhythmia associ‑
ated with excessive risk of ischemic stroke and 
heart failure as well as reduced life expectancy.1,2 
On the other hand, chronic coronary syndrome 
(CCS) remains the main cause of morbidity and 
mortality in an aging population. Both disease 
entities share common risk factors such as hy‑
pertension, diabetes, and obesity.3-5
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AbsTRACT
INTROduCTION Atrial fibrillation (AF) and chronic coronary syndrome (CCS) share common risk factors 
and frequently coexist. Additionally, AF symptoms may mimic CCS.
ObjECTIvEs The aim of the study was to investigate the hypothesis indicating absence of significant 
coronary lesions in patients with AF as compared with those with sinus rhythm.
PATIENTs ANd mEThOds We conducted a single ‑center retrospective study including consecutive 
patients referred for elective coronary angiography between 2007 and 2016.
REsuLTs The study population included 8288 patients out of whom 1674 had AF. There were substantial 
differences between groups with and without AF. Patients with AF were significantly older, more often 
were men and had diabetes, and more frequently were diagnosed with both chronic kidney disease and 
heart failure. On the other hand, they had history of hyperlipidemia less often. CCS was less frequently 
detected in patients with AF as compared with those with sinus rhythm (37.5% vs 41.1%; P <0.001). 
Additionally, the latter group more often underwent subsequent coronary angioplasty (19.2% vs 22.3%; 
P = 0.004). Multivariable analysis identified AF as an independent factor associated with absence of 
significant coronary lesions (odds ratio, 1.57; 95% CI, 1.32–1.87; P <0.001). Moreover, a comparison 
between patients with and without angiographically significant CCS revealed a higher prevalence of AF 
in the latter group (18.7% vs 21.2%; P = 0.006).
CONCLusIONs In our study, AF was associated with the absence of significant coronary lesions on angiog‑
raphy, reflecting difficulties with qualifying patients with AF for invasive CCS diagnostic workup. Our findings 
suggest the need for more efficacious noninvasive diagnostic approach for patients with AF and suspected CCS.
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medical history, physical examination, resting 
electrocardiogram, routine transthoracic echo‑
cardiogram, coronary angiogram, and percutane‑
ous coronary intervention (PCI). Eventually, our 
final study cohort included 8288 patients. Con‑
comitant diseases were defined via the Interna-
tional Statistical Classification of Diseases, Tenth 
Revision (ICD-10) codes, not prescription claims.
We analyzed whether history of AF was associ‑
ated with the absence of significant coronary le‑
sions on coronary angiography. We also investi‑
gated factors connected with the absence of signif‑
icant coronary lesions on angiography. The study 
protocol conformed to the ethical guidelines of 
the 1975 Declaration of Helsinki, and was ap‑
proved by the local ethics committee.
Coronary angiography All patients underwent cor‑
onary angiography and the number of diseased 
vessels were assessed. Coronary angiography was 
performed according to the Judkins technique.18 
Diagnosis of CCS and indication for PCI was per‑
formed according to the current European guide‑
lines.19 Significant stenosis of the coronary vessel 
was defined as more than 50% in the main stem 
of the left coronary artery and 70% in the rest of 
the epicardial arteries. The degree of CCS was clas‑
sified as single‑, double‑, or triple ‑vessel disease.
Echocardiographic analysis Left ventricular ejec‑
tion fraction (LVEF) was assessed in transtho‑
racic echocardiography using the modified bi‑
plane Simpson method (Philips Ultrasound Sys‑
tem, Sonos 5500, Aalborg, Denmark, equipped 
for harmonic imaging with a 3.6 MHz transduc‑
er) and was derived in accordance with the rec‑
ommendations of the  European Society of 
Echocardiography.20
definition of atrial fibrillation Atrial fibrillation was 
defined as the presence of AF on electrocardio‑
gram during the index hospitalization and / or as 
indicated by a diagnosis found in medical records, 
the hospital inpatient database, or outpatient da‑
tabases. Electrocardiographic AF was defined as 
an irregular rhythm with fibrillatory waves and 
no defined P waves. Diagnoses and AF classifica‑
tion were based on physician ‑assigned diagnoses 
in the medical records and / or the presence of cor‑
responding codes from the International Classifi-
cation of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD -9-CM) for AF (427.31) in the hospital 
discharge or outpatient databases. Atrial fibrilla‑
tion was further divided into the following cate‑
gories: paroxysmal AF or chronic AF (persistent 
and permanent).1
statistical analysis Continuous data were ex‑
pressed as means (SD) or medians and inter‑
quartile ranges (IQRs) when appropriate. Rel‑
ative frequencies were used to present cate‑
gorical variables. Normality of the distribution 
was assessed with the Kolmogorov–Smirnov 
test, while the 2 ‑tailed t test was applied for 
Patients with AF in the course of arrhyth‑
mia may present with chest pain, which can be 
accompanied by transient ischemic ‑type ST‑
‑segment changes, sometimes with marginally 
elevated cardiac necrosis markers, thus mimick‑
ing symptoms of CCS.16 There are contradictory 
data on angiographic findings among patients 
with AF.14 It is important to look at the preva‑
lence of significant CCS lesions in patients with 
AF compared with those with sinus rhythm to 
prevent unnecessary coronary angiography in 
patients with AF.
On the other hand, there are several studies 
including the ARIC (the Atherosclerosis Risk in 
Communities) study, the MESA (Multi ‑Ethnic 
Study of Atherosclerosis), and the Rotterdam 
Study which found an association between sub‑
clinical atherosclerosis and incident AF.17
The aim of the present study was to investi‑
gate the hypothesis indicating the absence of sig‑
nificant coronary lesions in patients with AF as 
compared with those with sinus rhythm referred 
for elective coronary angiography. This indicates 
that some patients with AF may have undergone 
coronary angiography needlessly.
PATIENTs ANd mEThOds We reviewed medical 
records of 26 985 patients hospitalized in the De‑
partment of Invasive Cardiology of the Medical 
University of Bialystok, Poland, who had coro‑
nary angiography performed because of exacer‑
bated angina (recurrent chest pain, classical sta‑
ble angina, long history of chest pain / angina, or 
other symptoms such as dyspnea) between 2007 
and 2016. The Bialystok Coronary Project is an ob‑
servational research project that includes hospi‑
talized patients with AF and CCS. It is focused 
on diagnostics and therapy of this population. 
We excluded patients with acute coronary syn‑
dromes (ACS), Takotsubo cardiomyopathy, and 
history of ischemic heart disease, as well as those 
referred for coronary angiography before heart 
valve surgery. Prior cardiosurgical valve replace‑
ment was also the exclusion criterion. The set of 
extracted variables included demographic data, 
whAT’s NEw?
In this study, the number of nonsignificant findings on coronary angiography 
was 1.6 ‑fold higher in patients with atrial fibrillation (AF) than in patients with‑
out AF. Atrial fibrillation was associated with absence of significant coronary 
lesions and patients with AF less frequently underwent coronary angioplasty 
as compared with those with sinus rhythm. This raises the possibility that 
it may be difficult to select patients with AF for invasive procedures, given 
the increased findings of nonsignificant chronic coronary syndromes (CCS) on 
coronary angiography. The reason for these findings might be multifactorial: 
AF symptoms mimic CCS symptoms, ST ‑segment depression during AF poorly 
predicts obstructive CCS, stress tests are rarely proceeded in patients with 
AF, and rapid rhythm makes computed tomography scan difficult to interpret. 
A more efficacious noninvasive diagnostic approach is needed in patients 
with AF and suspected CCS.
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REsuLTs Out of 26 985 patients admitted for 
elective coronary angiography, a total of 8288 pa‑
tients were included in the final analysis (FIGuRE 1, 
TAbLE 1). Over 80% of study participants had hy‑
pertension, 66.9% had hyperlipidemia, and 25.7% 
had diabetes. Chronic kidney disease (CKD) and 
chronic heart failure (CHF) were diagnosed in 
32.5% and 20.6% of the study population, re‑
spectively. Detailed characteristics of the study 
population is provided in TAbLE 2.
A total of 1674 (20.2%) patients had AF. Parox‑
ysmal AF was the most frequent type of the an‑
alyzed arrhythmia. However, we found only 
a marginally lower prevalence of permanent AF 
(FIGuRE 1).
Atrial fibrillation population There were substantial 
differences in terms of clinical characteristics be‑
tween groups with and without AF. Patients with 
AF were older, more often men, and more often 
had diabetes, and had higher body mass index and 
more frequently were diagnosed with both CKD 
and CHF. On the other hand, they were less like‑
ly to have history of hyperlipidemia. Mean (SD) 
HAS ‑BLED score was 2.14 (0.87), CHA2DS2 ‑VASc 
score was 3.99 (1.6).
The  highest mean (SD) HAS ‑BLED and 
CHA2DS2 ‑VASc scores were noted in patients with 
permanent AF: 2.2 (0.91) and 4.3 (1.6), respec‑
tively. In patients with paroxysmal AF, the mean 
(SD) HAS ‑BLED was 2.15 (0.84) and in persistent 
AF, it was 1.9 (0.81).
the comparative analysis of variables. Non‑
normally distributed data were compared with 
the Mann–Whitney test. Categorical variables 
were compared using the χ2 test. The multivari‑
able logistic regression backward stepwise Wald 
method was used to determine the odds ratio 
(OR) for the absence of significant coronary le‑
sions. A 2 ‑tailed P value of less than 0.05 was 
considered statistically significant. The IBM SPSS 
version 25.0 software package (SPSS, Chicago, 
Illinois, United States) was used.
FIGuRE 1 Flow chart of 
the study population 
selection 















Patients without coronary artery disease 
with significant stenosis
n = 3345






n = 26 985
Patients hospitalized in the Department of Invasive Cardiology of the Medical University of  
Białystok, Poland from January 2007 to December 2016
n = 8288
Patients met inclusion criteria and underwent coronary angiography
TAbLE 1 Characteristics of the screened population
Patients Value
All 26 985 (100)
Included in the final analysis 8288 (30.7)
Admitted for coronary angiography before heart valve 
surgery
3499 (13)
Hospitalized due to NSTEMI 3126 (11.6)
Hospitalized due to STEMI 3102 (11.5)
With history of ischemic heart disease 2940 (10.9)
Hospitalized due to UA 2503 (9.3)




Data are presented as number (percentage) of patients.
Abbreviations: NSTEMI, non–ST ‑segment elevation myocardial infarction; STEMI, 
ST ‑segment elevation myocardial infarction; UA, unstable angina
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TAbLE 2 Comparison between patients with and without atrial fibrillation (continued on the next page)
Variable All study participants 
(n = 8288)
Patients with AF 
(n = 1674)
Patients without AF 
(n = 6614)
P value
Male sex, n (%) 4500 (54) 1018 (61) 3482 (53) <0.001
Age, y, mean (SD) 65.2 (10.2) 68.6 (9.6) 64.3 (10.2) <0.001
BMI, kg/m2, mean (SD) 29.1 (4.9) 30 (5.2) 28.9 (4.7) <0.001
NYHA class, median (IQR) 2 (2–3) 3 (2–3) 2 (2–3) 0.22
CCS class, median (IQR) 2 (2–2) 2 (2–2) 2 (2–2) 0.26
CAD with significant stenosis on coronary angiography 3345(40.4) 627 (37.5) 2718 (41.1) <0.001
Single ‑vessel CAD 1507 (18.2) 342 (20.4) 1165 (17.6) <0.001
Double ‑vessel CAD 807 (9.7) 126 (7.5) 681 (10.3) <0.001
Triple ‑vessel and / or significant LM stenosis 1031 (12.4) 159 (9.5) 872 (13.2) <0.001
Hyperlipidemia 5548 (66.9) 961 (57.4) 4587 (69.4) <0.001
Hypertension 6886 (83.1) 1370 (81.8) 5516 (83.4) 0.14
Diabetes mellitus 2132 (25.7) 477 (28.5) 1655 (25) 0.005
Chronic heart failure 2690 (32.5) 1038 (62) 1652 (24.9) <0.001
HFrEF 1381 (51.3) 621 (59.8) 760 (46) <0.001
HFmrEF 599 (22.3) 220 (21.2) 379 (22.9)
HFpEF 710 (26.4) 197 (18.9) 513 (31.1)
Left ventricular ejection fraction, %, median (IQR) 55 (42–60) 45 (30–55) 56 (50–60) <0.001
Chronic kidney disease 1706 (20.6) 556 (33.2) 1150 (17.4) <0.001
Creatinine, mg/dl, median (IQR) 0.89 (0.78–1.05) 0.97 (0.82–1.17) 0.87 (0.78–1.02) <0.001
eGFR, ml/min/1.73 m2, mean (SD) 76.4 (19.1) 70 (20) 77.9 (18.5) <0.001
eGFR >90 ml/min/1.73 m2 2095 (26) 266 (16.4) 1829 (28.6) <0.001
eGFR 60–90 ml/min/1.73 m2 4455 (55.2) 855 (52.8) 3600 (55.9)
eGFR 45–60 ml/min/1.73 m2 967 (12) 302 (18.6) 665 (10.3)
eGFR 30–45 ml/min/1.73 m2 406 (5) 161 (9.9) 245 (3.8)
eGFR 15–30 ml/min/1.73 m2 79 (0.9) 27 (1.7) 52 (0.1)
eGFR <15 ml/min/1.73 m2 63 (0.8) 10 (0.6) 53 (0.9)
RBC, 106/mm3, median (IQR) 4.58 (4.28–4.88) 4.58 (4.23–4.89) 4.58 (4.29–4.8) <0.001
Total cholesterol, mg/dl, median (IQR) 171 (146–203) 167 (141–198) 172 (148–204) 0.006
High ‑density lipoprotein cholesterol, mg/dl, median (IQR) 46 (39–55) 45 (38–53) 47 (39–56) <0.001
Low ‑density lipoprotein cholesterol, mg/dl, median (IQR) 99 (77–127) 97 (75–124) 99 (78–128) 0.037
Triglycerides, mg/dl, median (IQR) 117 (85–165) 113 (82–159) 118 (85–167) 0.4
Presence of any significant stenosis on coronary 
angiography
3345 (40.4) 627 (37.5) 2718 (41.1) <0.001
LM stenosis 245 (3) 42 (2.5) 203 (3.1) 0.2
LAD stenosis 2013 (24.3) 336 (20.1) 1677 (25.3) <0.001
DIAG stenosis 735 (8.9) 132 (7.9) 603 (9.1) 0.09
Cx stenosis 1096 (13.2) 174 (10.4) 922 (14) <0.001
OM stenosis 664 (8) 104 (6.2) 560 (8.5) <0.001
RCA stenosis 1481 (17.9) 224 (13.4) 1257 (19) <0.001
Patients qualified for conservative management 5330 (64.3) 1126 (67.3) 4204 (63.6) 0.004
Patients qualified for the Heart Team discussion 1161 (14) 227 (13.6) 934 (14.1) 0.55
Patients treated with PCI 1796 (21.7) 321 (19.2) 1475 (22.3) 0.004
PCI LM 34 (0.4) 7 (0.4) 27 (0.4) 0.95
PCI LAD 1115 (13.4) 206 (12.3) 909 (13.7) 0.11
PCI DIAG 182 (2.2) 34 (2) 148 (2.2) 0.6
PCI Cx 451 (5.4) 81 (4.9) 370 (5.6) 0.2
PCI OM 61 (0.7) 13 (0.8) 48 (0.7) 0.83
PCI RCA 404 (4.9) 64 (3.8) 340 (5.1) 0.015
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bleeding. In 19 patients, cardiac arrest occurred 
during hospitalization: 7 patients (0.4%) with AF 
and 12 patients with sinus rhythm (0.2%). Over‑
all composite complications were more common 
in patients with AF.
dIsCussION In this study, nonsignificant find‑
ings on coronary angiography were 1.6 ‑fold high‑
er in patients with AF than in patients without 
AF. Second, AF was associated with significantly 
less atherosclerotic narrowing on coronary angi‑
ography (627 [37.5%] vs 2718 [41.1%] in patients 
without AF; P <0.001) and patients with AF less 
frequently underwent coronary angioplasty as 
compared with the population with sinus rhythm. 
This raises the possibility that AF may result in 
difficulties in selecting patients with AF for in‑
vasive procedures, given the increased findings 
of nonsignificant CCS on coronary angiography.
The reason for these findings might be com‑
plex and multifactorial. Patients with AF often 
present with typical or atypical chest pain, tran‑
sient ST ‑segment depression, and elevated car‑
diac markers. These findings may mimic symp‑
toms of CCS.21 Moreover, rapid tachycardia is of‑
ten observed in patients with AF, and ST ‑segment 
changes at these rates have been linked with myo‑
cardial ischemia. For example, Tsigkas et al21 re‑
ported ST ‑segment depression in 38% of patients 
with AF and rapid rhythm and only about 50% 
of these patients had significant CCS on coro‑
nary angiography. ST ‑segment depression may 
frequently occur during significant tachycardia, 
even without CCS, and it is not necessarily typi‑
cal for cardiac ischemia if the ST segment depres‑
sion is less than 2 mm.21,22
Moreover, ST ‑segment depression during rap‑
id AF has less significant value than ST ‑segment 
depression during exercise tests in patients with 
sinus rhythm.23 Only 4% of patients without ST‑
‑segment depression during rapid AF had posi‑
tive noninvasive tests for myocardial ischemia 
and CCS on angiography.23 Troponin release was 
shown in 15% of patients with AF and symptoms 
of ischemia, although CCS at angiography was ab‑
sent.25 In a database of patients referred for cor‑
onary angiography, history of AF correlated with 
no obstructive CCS.24,26
On the other hand, Kralev et al27 showed that 
left main stem and right coronary artery (RCA) 
disease was present more frequently in patients 
with AF compared with controls. They also sug‑
gested that significant atherosclerotic narrowing 
The lowest mean (SD) CHA2DS2 ‑VASc score was 
noted in the group of patients with paroxysmal 
AF (3.74 [1.5]). In the group of patients with per‑
sistent AF, the mean (SD) CHA2DS2 ‑VASc score 
was 3.87 (1.5). A detailed comparison between 
the 2 groups is shown in TAbLE 2.
Coronary angiography Out of 8288 patients who 
underwent coronary angiography, significant le‑
sions were found in 3345 study participants 
(40.4%). Importantly, patients without signifi‑
cant CCS were more frequently women and more 
commonly presented with AF (TAbLE 3). Addition‑
ally, CCS was markedly less frequently detect‑
ed on coronary angiography in patients with AF 
than in those with sinus rhythm. Furthermore, 
the latter group significantly more often under‑
went subsequent coronary angioplasty (TAbLE 2).
Predictors of nonsignificant coronary findings in the 
multivariable analysis In the logistic regression 
model, the odds ratio of nonsignificant findings 
on coronary angiography were 1.6 ‑fold higher 
in patients with AF than in those without AF 
(OR, 1.57; 95% CI, 1.32–1.87; P <0.001). The in‑
dexed OR for a 5‑kg/m2 increase in body mass 
index was 1.24 (95% CI, 1.15–1.35; P <0.001), 
and for a 5‑mg/ml increase in high ‑density lipo‑
protein cholesterol concentration, 1.16 (95% CI, 
1.1–1.24; P <0.001). The OR for CHF was 0.68 
(95% CI, 0.56–0.83; P <0.001), other cardiovas‑
cular risk factors such as hypercholesterolemia, 
0.64 (95% CI, 0.55–0.75; P <0.001), diabetes, 0.69 
(95% CI, 0.59–0.81; P <0.001), hypertension, 0.68 
(95% CI, 0.56–0.82; P <0.001), CKD, 0.79 (95% 
CI, 0.66–0.94; P <0.001) and women as compared 
with men, 0.39 (95% CI, 0.34–0.46; P <0.001). Ad‑
ditionally, for a 10 ‑year increase in age, the OR 
was 0.71 (95% CI, 0.65–0.76; P <0.001; FIGuRE 2)
Complications of coronary angiography There were 
48 cases of significant vascular complications re‑
lated to the puncture of the site (0.5%). In 75% 
of complications, the femoral artery was affect‑
ed, and in 25% of cases, it was the radial artery. 
Out of those cases, 16 (1%) were patients with 
AF and 32 (0.4%) had sinus rhythm (P = 0.004).
In 9 patients (0.11%), neurological disorders 
associated with the procedure were recorded in 
7 patients (0.1%) with sinus rhythm and in 2 pa‑
tients (0.12%) with AF. All computed tomogra‑
phy (CT) examinations performed in these pa‑
tients failed to show any signs of intracranial 
TAbLE 2 Comparison between patients with and without atrial fibrillation (continued from the previous page)
Data are presented as number (percentage) of patients unless otherwise indicated. The percentage is calculated within the subgroup.
Abbreviations: BMI, body mass index; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society Angina Grading Scale; Cx, circumflex 
artery; DIAG, diagonal artery; eGFR, estimated glomerular filtration rate; HFmrEF, heart failure with moderate ejection fraction; HFpEF, heart failure with 
preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; IQR, interquartile range; LAD, left anterior descending; LM, left main 
artery; NYHA, New York Heart Association Functional Classification; OM, left marginal artery; PCI, percutaneous coronary intervention; RBC, red blood 
cells; RCA, right coronary artery; others, see FIGuRE 1
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that in patients with AF, ischemia at the level of 
microcirculation of the myocardial muscle (rather 
than epicardial vessels) is responsible for the pres‑
ence of typical angina. Unfortunately, our study 
did not explore the impact of cardiac ischemia in‑
duced by coronary small ‑vessel disease.
Our findings reflect difficulties with selecting 
AF patients for invasive coronary investigations. 
In the general population, the sensitivity of ex‑
ercise testing ranges from 60% to 70% and spec‑
ificity is approximately 85%.29 As mentioned be‑
fore, ST ‑segment depression is a common finding 
in AF patients,30 and ST ‑depression during rap‑
id AF has relatively higher sensitivity and lower 
specificity, when compared with exercise testing. 
Thus, the absence of ST ‑depression during rap‑
id AF has satisfactory sensitivity for excluding 
significant CCS.21 Low positive predictive values 
in the proximal RCA and the circumflex artery 
(Cx) prior to the take off of the atrial arteries rais‑
es the risk of AF. In our study, significant RCA and 
Cx disease were less common than in patients 
with sinus rhythm. Another analysis of 3220 pa‑
tients referred for coronary angiography revealed 
that only 43% of patients with CCS and AF had 
a diseased RCA or Cx.21
Does AF contribute to CCS or vice versa? There 
is a debate on this topic and opinions are often 
contradictory. Motloch et al28 found that the an‑
atomical distribution of coronary artery stenoses 
did not contribute to AF in CCS patients; how‑
ever, AF was linked to worse CCS severity, which 
might predispose individuals to AF by driving 
ischemic heart disease and changes in left ven‑
tricular function. In our study, patients with AF 
had less prevalent multivessel CCS. It is possible 
TAbLE 3 Comparison between patients with and without angiographically significant coronary artery disease
Variable Patients with CAD 
(n = 3345)
Patients without CAD 
(n = 5483)
P value
Male sex 2238 (67) 2262 (46) <0.001
Age, y, mean (SD) 66.9 (9.7) 64 (10.3) <0.001
BMI, kg/m2, mean (SD) 28.8 (4.6) 29.33 (5) <0.001
NYHA class, median (IQR) 3 (4–3) 2 (2–3) 0.04
CCS class, median (IQR) 2 (2–2) 2 (2–2) 0.03
Left ventricular ejection fraction, %, median (IQR) 55 (44–60) 55 (42–60) 0.5
Chronic heart failure 1247 (37.3) 1443 (29.2) <0.001
HFrEF 601 (48.2) 780 (54.1) <0.001
HFmrEF 301 (24.1) 298 (20.6)
HFpEF 345 (27.7) 365 (25.3)
Hyperlipidemia 2348 (70.2) 3200 (64.7) 0.001
Hypertension 2891 (86.4) 3995 (80.8) <0.001
Diabetes mellitus 1014 (30.3) 1118 (22.6) <0.001
AF Any 627 (18.7) 1047 (21.2) 0.006
Paroxysmal 267 (42.6)a 490 (46.8)a 0.09
Persistent 69 (11)a 125 (11.9)a 0.56
Permanent 291 (46.4)a 432 (41.3)a 0.04
Chronic kidney disease 824 (24.6) 882 (17.9) <0.001
Creatinine, mg/dl, median (IQR) 0.93 (0.81–1.1) 0.86 (0.77–1.01) <0.001
eGFR, ml/min/1.73 m2, mean (SD) 70 (20) 77.8 (18.6) <0.001
eGFR >90 ml/min/1.73 m2 754 (23.2) 1341 (27.9) <0.001
eGFR 60–90 ml/min/1.73 m2 1775 (54.5) 2680 (55.7)
eGFR 45–60 ml/min/1.73 m2 441 (13.6) 526 (10.9)
eGFR 30–45 ml/min/1.73 m2 214 (6.6) 192 (4)
eGFR 15–30 ml/min/1.73 m2 37 (1.1) 42 (0.1)
eGFR <15 ml/min/1.73 m2 32 (1) 31 (0.6)
RBC, 106/mm3, median (IQR) 4.58 (4.26–4.89) 4.58 (4.28–4.87) 0.55
Total cholesterol, mg/dl, median (IQR) 169 (144–200) 173 (147–204) 0.008
High ‑density lipoprotein cholesterol, mg/dl, median (IQR) 44 (38–52) 48 (40–57) 0.075
Low ‑density lipoprotein cholesterol, mg/dl, median (IQR) 99 (77–125) 99 (77–128) 0.006
Triglycerides, mg/dl, median (IQR) 121 (87–170) 114 (83–162) 0.34
Data are presented as number (percentage) of patients unless otherwise indicated.
a The percentage is calculated within the sub group.
Abbreviations: see FIGuRE 1 and TAbLE 2
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during daily clinical practice. Second, we excluded 
from our analysis patients with ACS. Third, frac‑
tional flow reserve measurements were not per‑
formed on regular basis. This could cause an in‑
accurate assessment of the significance of coro‑
nary stenosis. Therefore, only cases of stenosis 
with a reduction of 70% were defined as signif‑
icant.32 Fourth, we were able neither to reliably 
assess stress tests before invasive diagnostics nor 
to measure concentrations of natriuretic pep‑
tides. Fifth, our study did not explore the impact 
of myocardial ischemia induced by coronary mi‑
crovascular disease. Six, patients with AF were 
less likely to have lipid disorders, which may af‑
fect the results. Seven, due to a very large group 
of patients included in the study (nearly 10 000) 
and nearly 10 years of analysis (2007–2016), we 
were unable to obtain reliable data on smoking 
in the analyzed group. Over the years, the ap‑
proach to smoking addiction and the way it is 
coded has changed. Our diagnoses were based 
on the diagnoses established by the physicians in 
charge and were not verified again. Additionally, 
it would be interesting to perform more detailed 
echocardiographic examinations of all study par‑
ticipants. Furthermore, retrospective chart da‑
tabases provide easy and cheap access to large 
numbers of patients although limitations such 
as potential selection bias should be taken into 
consideration. The last thing, one of the subtypes 
of AF is newly diagnosed AF. As there is no spe‑
cific ICD code for it, we were not able to distin‑
guish this type of AF. 
Conclusions In our study, AF was associated with 
the absence of significant coronary lesions on an‑
giography and less frequent need for revascular‑
ization, reflecting difficulties with qualifying AF 
patients for invasive CCS diagnostic workup. Mul‑
tiple factors might be the reason for these find‑
ings, namely, AF symptoms may mimic CCS symp‑
toms, ST ‑segment depression during AF pootly 
for significant CCS of ST ‑segment depression 
have been reported at approximately 32%.23,24 
Patients with AF are not optimal candidates for 
coronary CT angiography during a rapid cardiac 
rhythm. However, it is a good diagnostic modal‑
ity for patients in sinus rhythm with low CCS 
probability.
Not only are patients with AF improperly re‑
ferred for invasive coronary investigations, but 
they are at an increased risk of complications. In 
a study of 13 498 patients, it was shown that pa‑
tients with a history of AF were more likely to 
have post procedural bleeding, more often need‑
ed blood transfusion, and more often had exacer‑
bation of heart failure, cardiogenic shock, and in‑
‑hospital mortality, but there were no differenc‑
es in the incidence of postprocedural stroke or 
vascular complications in matched cohorts.30,31 
Similarly, several studies reported that AF pa‑
tients were more likely to experience postpro‑
cedural heart failure and cardiogenic shock.32-34 
In the present study, there were 48 cases of sig‑
nificant vascular complications concerning fem‑
oral and radial artery related to the puncture of 
the site, and were more frequent in patients with 
AF than patients with sinus rhythm. Also, neu‑
rological disorders associated with the procedure 
were recorded more frequently in patients with 
AF than those with sinus rhythm. All CT exami‑
nations performed thereafter did not show signs 
of intracranial bleeding. Cardiac arrest during hos‑
pitalization was numerically higher in patients 
with AF. Apart from this, it was already demon‑
strated that AF patients with NSTEMI undergo‑
ing PCI can be predisposed to contrast induced 
nephropathy.35 
Limitations Our study has several limitations. 
First, our findings were obtained in a retrospec‑
tive single ‑center study and should be confirmed 
in a multicenter prospective study. However, our 
data represent real life, as they were obtained 
FIGuRE 2 Multivariable 
logistic regression 
analysis of nonsignificant 
lesions in the coronary 
artery. Data are presented 
as odds ratios and their 
95% CI. 
Abbreviations: 
CHF, chronic heart failure; 
CKD, chronic kidney 
disease; DM, diabetes 
mellitus; HA, hypertension; 
HDL, high ‑density 
lipoprotein; 
HL, hyperlipidemia; others, 








HA HL HDL              
(5 mg/dl) 





P value for all variables <0.001
R2 Nagelkerke = 0.14
Overall prediction rate = 64.1%
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predicts obstructive CCS, stress tests are rarely 
proceeded in patients with AF, and rapid rhythm 
makes CT scan difficult to interpret. Our findings 
suggest the need for a more efficacious noninva‑
sive diagnostic approach for patients with AF and 
suspected CCS.
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